Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9100+0.0300 (+1.60%)
At close: 04:00PM EDT
2.0100 +0.10 (+5.24%)
After hours: 05:41PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
1,445
208,383
12,617
0
0
Operating Expense
70,060
84,173
94,048
61,410
52,932
Operating Income
-68,615
124,210
-81,431
-61,410
-52,932
Net Non Operating Interest Income Expense
-
-
-
948.224
952.073
Other Income Expense
213.092
-45.69
395.401
-
-
Pretax Income
-68,402
124,163
-81,036
-60,461
-51,980
Tax Provision
878.541
1,329
-
-
-
Net Income Common Stockholders
-64,837
119,839
-81,036
-60,461
-51,980
Diluted NI Available to Com Stockholders
-64,837
119,839
-81,036
-60,461
-51,980
Basic EPS
-
1.78
-1.39
-1.54
-2.11
Diluted EPS
-
1.76
-1.39
-1.54
-2.11
Basic Average Shares
-
67,479
58,451
39,217
24,631
Diluted Average Shares
-
68,068
58,451
39,217
24,631
Total Operating Income as Reported
-68,615
124,209
-81,431
-61,409
-52,932
Total Expenses
70,060
84,173
94,048
61,410
52,932
Net Income from Continuing & Discontinued Operation
-69,281
122,835
-81,036
-60,461
-51,980
Normalized Income
-69,281
122,835
-81,036
-60,461
-51,980
Interest Income
-
-
-
948.224
952.073
Net Interest Income
-
-
-
948.224
952.073
EBIT
-68,615
124,210
-81,431
-61,410
-52,932
EBITDA
-68,378
-
-
-
-
Reconciled Depreciation
236.151
237.079
306.848
255.002
141.733
Net Income from Continuing Operation Net Minority Interest
-69,281
122,835
-81,036
-60,461
-51,980
Normalized EBITDA
-68,378
124,447
-81,124
-61,155
-52,790
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement